Achiko AG (XSWX:ACHI) Total Long-Term Assets : CHF1.43 Mil (As of Jun. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Achiko AG Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Achiko AG's Total Long-Term Assets for the quarter that ended in Jun. 2022 was CHF1.43 Mil.

Achiko AG Total Long-Term Assets Historical Data

The historical data trend for Achiko AG's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achiko AG Total Long-Term Assets Chart

Achiko AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Total Long-Term Assets

1.71

1.76

0.28

0.44

Achiko AG Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Total Long-Term Assets	Get a 7-Day Free Trial			1.75	0.28	0.36	0.44	1.43

Achiko AG Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Achiko AG Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Achiko AG's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Achiko AG (XSWX:ACHI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Achiko AG (XSWX:ACHI) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tessinerplatz 7, Zurich, CHE, CH-8002

Website

https://www.achiko.com

Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.

Achiko AG (XSWX:ACHI) Headlines

No Headlines